Navigation Links
Effective Pain Relief For Patients Suffering From Multiple Sclerosis

Dronabinol, shows success reducing pain in patients with multiple sclerosis, according to a new study published . Dronabinol, also known as Marinol, has been used to soothe nausea and to stimulate appetite.// Researchers evaluated the effect of Dronabinol on pain in patients with multiple sclerosis.

24 patients with multiple sclerosis and central pain participated in the study . They were given up to 10 milligrams of dronabinol or a placebo for three weeks. Patients reported pain intensity was significantly lower and pain relief was higher during dronabinol treatment. The difference between treatments in pain reduction was about 21 percent. Pressure-evoked pain also tended to decrease, and patients reported better quality of life with dronabinol. The functional ability of the patients was not affected.

Adverse effects, dizziness being the most common, were more frequent with dronabinol than with placebo. Acute or chronic pain, including musculoskeletal pain, pain associated with spasms and central pain, occur in 30 percent to 80 percent of patients with multiple sclerosis. However, no patients stopped treatment because of adverse effects, which reportedly decreased after the first week of treatment.

Thus researchers conclude that dronabinol should be available for patients whose central pain from multiple sclerosis is not sufficiently treated with alternative drugs.
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... 23, 2017 , ... Benefits delivery trailblazer, Hodges-Mace, LLC, ... centralized benefits dashboard solving one of the top frustrations in employee benefits – ... first time, employees can access up-to-date information and account balances for all of ...
(Date:3/23/2017)... CO (PRWEB) , ... March 23, 2017 , ... ... serving the families and businesses of the greater Fort Collins area, has unveiled ... in their ongoing community involvement program. Donations to this worthy cause may now ...
(Date:3/23/2017)... ... 23, 2017 , ... ChenMed, a privately owned medical, management ... strategic executive team expansion needed to further optimize growth and performance. , “We ... Christopher Chen, MD, ChenMed Chief Executive Officer. “George Wheeler and Donald Trexler ...
(Date:3/23/2017)... ... ... Inflow IQ & Inflownomics of Raleigh, NC introduce a powerful information access ... As experts in dangerous situations the Inflow IQ team can help people. Get ... clean & refreshing knowledge systems that enhance life. , Authentically enjoy ...
(Date:3/23/2017)... ... March 23, 2017 , ... On 2 March 2017, ... US Special Operations Command’s Patriot Award. The award was presented by the USSOCOM ... Dagger Foundation for its significant and enduring support to the command. , ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... Denmark , March 23, 2017 Ascendis ... its innovative TransCon technology to address significant unmet medical ... will host a conference call and webcast on Monday, ... the Endocrine Society in Orlando, Florida ... disease pipeline candidates (TransCon Growth Hormone, TransCon PTH and ...
(Date:3/23/2017)... 2017  Cornerstone Pharmaceuticals, Inc., a clinical-stage, ... today.  Following successful End-of-Phase I (EOP1) Type ... Drug Administration (FDA), the Company has been ... forward to conduct pivotal trials of its ... myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... AVIV, Israel , March 23, 2017 ... on oncology and immunology, announced today that it has acquired ... immunotherapy platform. Acquisition consideration consisted of a $6 million upfront ... remainder in BioLineRx shares. Additional future payments may be made ... ...
Breaking Medicine Technology: